CCA WGS data (16 CCA with matched normal, 4 cell-line)
Fastq files for WGS for 16 CCAs (with matched normal tissues), and 4 cell lines in an AA-treatment experiment (0, 10, 20, 40ug AA treatment after 180 days; 2 runs each for 10ug and 40ug experiments). Genomic DNA was extracted using DNeasy Blood and Tissue Kit (Qiagen). Sequencing libraries were prepared from DNA extracted using the SureSelect XT2 Target Enrichment System for the Illumina Multiplexed Sequencing platform (Illumina) according to the manufacturer’s instructions. Whole genome sequencing was performed on Illumina HiSeq4000 sequencer with paired-end sequencing.
- 36 samples
- DAC: EGAC00001003452
- Technology: Illumina HiSeq 4000
- HMB DUO:0000006 (version: 2021-02-23)health or medical or biomedical researchThis data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.
- NPUNCU DUO:0000018 (version: 2021-02-23)not for profit, non commercial use onlyThis data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.
- COL DUO:0000020 (version: 2021-02-23)collaboration requiredThis data use modifier indicates that the requestor must agree to collaboration with the primary study investigator(s).
- IRB DUO:0000021 (version: 2021-02-23)ethics approval requiredThis data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
- PS DUO:0000027 (version: 2021-02-23)project specific restrictionThis data use modifier indicates that use is limited to use within an approved project.
- NPOA DUO:0000044 (version: 2021-02-23)population origins or ancestry research prohibitedThis data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited.
- NPU DUO:0000045 (version: 2021-02-23)not for profit organisation use onlyThis data use modifier indicates that use of the data is limited to not-for-profit organizations.
- NCU DUO:0000046 (version: 2021-02-23)non-commercial use onlyThis data use modifier indicates that use of the data is limited to not-for-profit use.
Enhancer studies on CCA
DUO:0000006 health/medical/biomedical research and clinical care This primary category consent code indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry. DUO:0000020 collaboration required This requirement indicates that the requestor must agree to collaboration with the primary study investigator(s). DUO:0000021 ethics approval required This requirement indicates that the requestor must provide documentation of local IRB/ERB approval. DUO:0000018 not-for-profit use only This requirement indicates that use is limited to not-for-profit organizations. DUO:0000044 population origins or ancestry research prohibited This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited. DUO:0000045 not for profit organisation use only This data use modifier indicates that use of the data is limited to not-for-profit organizations. DUO:0000046 non-commercial use only This data use modifier indicates that use of the data is limited to not-for-profit use. DUO:0000027 project-specific restriction This requirement indicates that use is limited to use within an approved project. DUO:0000044 population origins or ancestry research prohibited This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001007309 | Epigenetics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.